Label-free Array Systems Market

Label-free Array Systems Market (Technique: Surface Plasmon Resonance, Microcantilever, Scanning Kelvin Nanoprobe, Enthalpy Array and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Label-free Array Systems Market Outlook 2031

  • The global label-free array systems market was valued at US$ 1.3 Bn in 2021
  • The global market is projected to grow at a CAGR of 6.4% from 2022 to 2031
  • The global label-free array systems market is anticipated to reach more than US$ 2.4 Bn by the end of 2031

Analysts’ Viewpoint on Label-free array systems Market Scenario

Label-free array systems have gained popularity as primary research tools in different drug discovery processes over the last few years. Manufacturers are generating biorelevant data using label-free technologies and patient samples, which could help in efficient drug development and precision medicine. Modern medicine is moving toward precision or personalized medicine to eliminate individual dosing redundancy. Businesses are also concentrating on developing appropriate readout systems and cellular models in order to grasp mechanisms and functional studies on a molecular and cellular level. Mass spectroscopy, biochips/microarrays, and other cutting-edge label-free techniques have also shown promise in locating clinical microorganisms. Manufacturers are developing specially formulated imaging biosensors that can be incorporated into microplates to detect molecules, cell lines, and proteins. This is likely to present significant opportunities for players in the global label-free array systems market in the near future.

Label Free Array Systems Market

Label-free Array Systems Market Introduction

Label-free detection techniques are employed more often than conventional label-based detection techniques to study molecular interactions. Label-free detection has become vital in applications where label detection could compromise the target characteristic. Usage of heavy fluorescent or other labels is not necessary when using label-free array techniques to find new molecules. In comparison to the conventional labelled technique, the label-free array technique offers a number of benefits including quick delivery, dependability, reliability, and accurate real-time results. Label-free array techniques are less expensive overall, as no radioactive or fluorescent labels, tags, dye, or specialized reagents are needed for the preparation of the assay.

Advancements in material science, nanotechnology, and computational configuration have led to development of label-free microarray methods such as label-free protein microarrays and label-free biosensor arrays. These methods are quite helpful in understanding disease signaling pathway, protein profiling, biomarker screening, drug discovery, drug target identification, and drug target identification.

Request a sample to get extensive insights into the Label-free Array Systems Market

Real-time Monitoring of Biomolecules Driving Investment in Surface Plasmon Resonance Technology

The usage of surface plasmon resonance (SPR) technology as an optical detection technique for biosensors is gaining popularity. Better understanding and acceptance of the technology is excepted to increase the usage of SPR in clinical chemistry and medicine. The global label-free array systems market size is anticipated to grow at a steady pace during the forecast period owing to the rise in awareness and acceptance of these systems. These techniques reduce cost and time, and offer high throughput results in real time. Label-free methods deliver dependable, quick, and accurate results in less time than conventional methods. Additionally, label-free methods offer real-time data on binding kinetics, affinity, and other crucial analyses, thereby cutting down on the overall processing time.

Growth in Demand for Atomic Force Microscopy to Propel Label-free Array Systems Market Share

Atomic force microscopy (AFM) is a potent method for capturing images of nearly any surface including glass, ceramics, composites, polymers, and biological material. AFM is used to quantify and locate a large spectrum of forces including magnetic force and mechanical properties. It can be used to examine cells and molecules at the nanometer scale. It can now be used to diagnose and conduct cancer research. Living cells' physicochemical characteristics change as their changes in physiological conditions. Therefore, these physicochemical characteristics could represent intricate physiological processes that take place in cells. Morphology, elasticity, and adhesion characteristics of cells can change when they are going through the carcinogenesis process and are provided external stimuli. In order to study the mechanical properties of live cells, AFM can perform atomic resolution surface imaging and ultrastructural observation of the cells under conditions that are close to physiological conditions. AFM has the potential to be used as a high-resolution research tool to study the ultrastructure and mechanical characteristics of tumor cells.

Request a custom report on Label-free Array Systems Market

Rise in Demand for Advanced Systems that Achieve Productive Drug Discovery Processes

The cost and time required to deliver new drugs for clinical use have increased over the last three decades. Attempts to increase the number of compounds entering the drug development pipeline have largely been unsuccessful despite the rise in financial assets in research infrastructure by pharma firms and technical advances in scientific tools. Delivery of new medicines has not become effective despite the increase in cost of drug discovery projects. On the contrary, fewer medications than ever before are passing through the drug development process. The industry's overreliance on high-tech platforms, strict requirements for new drug registration & approval, and exhaustion of obvious and accessible drug targets—all these require the investigation of more complex biological systems—are the primary causes of the productivity decline. These factors are likely to drive the global label-free array systems market in the next few years.

Increase in Demand for Microcantilevers in Clinical Applications

In terms of technique, the global label-free array systems market has been classified into surface plasmon resonance, microcantilever, scanning kelvin nanoprobe, enthalpy array, atomic force microscopy, electrochemical impedance spectroscopy, interference-based technique, ellipsometry technique, and others. Microcantilevers can be used to measure a range of physical, chemical, and even biochemical variables. Microcantilever array detection increases accuracy through the usage of several sensors concurrently. This increased dependability is especially significant for practical applications. Multiple chemical or biological analysts can be detected simultaneously using group-produced microcantilever arrays. Applications could be made for clinical, industrial, military, and consumer markets. This would be particularly true once several target molecule mixtures can be examined and screened on a single, tiny chip.

Surge in Usage of Novel Targeted Drugs in Life Sciences and Pharmaceutical Industries Fueling Drug Discovery Segment

Based on application, the drug discovery segment held major share of the global market in 2021. Rise in application of label-free techniques in drug discovery, increase in R&D costs, and surge in demand for new and targeted drugs in life sciences and pharmaceutical industries are the key drivers of the drug discovery segment. Label-free methods, such as the detection and measurement of a local change in refractive index, can be used to study various interactions, including those between a drug molecule and its receptor. The drug discovery segment is anticipated to witness strong growth during the forecast period due to the increase in government funding for label-free array system market research and rise in label-free technique applications.

Rise in R&D Investments to Propel Pharmaceutical & Biotechnology Industries Segment

In terms of end-user, the global label-free array systems market has been divided into contract research organizations, academic & research institutes, pharmaceutical & biotechnology industries, and others. The pharmaceutical & biotechnology industries segment is anticipated to grow at a rapid pace in the next few years. Increase in R&D investments by pharmaceutical and biotech companies is the major factor propelling the segment. Several companies focus on the development of novel and targeted drugs in order to gain a competitive edge in the highly fragmented industry.

Regional Outlook of Global Label-free Array Systems Market

North America accounted for major share of the global label-free array systems market in 2021. The region is expected to emerge as a market leader in label-free array systems in the next few years. This can be ascribed to the increase in drug discovery programs in the U.S. owing to the rise in incidence of chronic and life-threatening diseases. In turn, this is likely to drive the demand for label-free array systems in the country. Label-free cell-based systems are also being introduced by companies for early drug discovery.

The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. This can be ascribed to the growth in focus on new therapy development, availability of funds, increase in number of drug discovery projects, and rise in demand for monoclonal antibodies.

Analysis of Key Players in Global Label-free Array Systems Market

The global label-free array systems market is consolidated, with the presence of small number of leading players. Most of the companies are investing significantly in research & development activities, primarily to introduce advanced label-free array systems products. Key players are entering into strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the prominent strategies adopted by the leading players. GE Healthcare, Attana AB, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., and BiOptix, Inc. are the key players operating in the global label-free array systems market.

Key Developments in Global Label-free Array Systems Market

  • In November 2018, Agilent Technologies, Inc. acquired ACEA Biosciences, Inc. (ACEA) in order to expand its label-free array systems portfolio
  • In June 2018, Germany-based Sierra Sensors GmbH was purchased by Bruker. Sierra develops and manufactures innovative analytical biosensors based on surface plasmon resonance (SPR) detection. A new benchmark in high-throughput and high-performance label-free analysis is being set by Sierra instruments, which are powered by patented technologies in the fields of SPR detection and microfluidic sample delivery.

Each of these players has been profiled in the label-free array systems market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Label-free Array Systems Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 1.3 Bn

Market Forecast Value in 2031

More than US$ 2.4 Bn

Growth Rate (CAGR)

6.4%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Technique
    • Surface Plasmon Resonance
    • Microcantilever
    • Scanning Kelvin Nanoprobe
    • Enthalpy Array
    • Atomic Force Microscopy
    • Electrochemical Impedance Spectroscopy
    • Interference-based Technique
    • Ellipsometry Technique
  • Application
    • Drug Discovery
    • Biomolecular Interactions
    • Detection of Disease Biomarkers
    • Others
  • End-user
    • Contract Research Organizations
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Industries
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Companies Profiled

  • GE Healthcare
  • Attana AB
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • GWC Technologies
  • PerkinElmer, Inc.,
  • BiOptix, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global label-free array systems market in 2021?

The global label-free array systems market was valued at US$ 1.3 Bn in 2021

How big will be the global label-free array systems market in 2031?

The global label-free array systems market is projected to reach more than US$ 2.4 Bn by 2031

What will be the CAGR of the global label-free array systems market during the forecast period (2022–2031)?

The global label-free array systems market is anticipated to grow at a CAGR of 6.4% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in investment in surface plasmon resonance technology and rise in demand for atomic force microscopy

What is the market share of the leading segment of the global label-free array systems market?

The surface plasmon resonance segment held more than 31% share of the global label-free array systems market in 2021

Who are the prominent players in the global label-free array systems market?

GE Healthcare, Attana AB, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., and BiOptix, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Label-free Array Systems Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Label-free Array Systems Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Key Mergers & Acquisitions

        5.2. Technological Advancements

        5.3. Healthcare Industry Overview

        5.4. Regulatory Scenario, by Region/globally

    6. Global Label-free Array Systems Market Analysis and Forecast, by Technique

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Surface Plasmon Resonance

            6.3.2. Microcantilever

            6.3.3. Scanning Kelvin Nanoprobe

            6.3.4. Enthalpy Array

            6.3.5. Atomic Force Microscopy

            6.3.6. Electrochemical Impedance Spectroscopy

            6.3.7. Interference-based Technique

            6.3.8. Ellipsometry Technique

            6.3.9. Others

        6.4. Market Attractiveness Analysis, by Technique

    7. Global Label-free Array Systems Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Drug Discovery

            7.3.2. Biomolecular Interactions

            7.3.3. Detection of Disease Biomarkers

            7.3.4. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Label-free Array Systems Market Analysis and Forecast, by Application

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Contract Research Organizations

            8.3.2. Academic & Research Institutes

            8.3.3. Pharmaceutical & Biotechnology Industries

            8.3.4. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Label-free Array Systems Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Label-free Array Systems Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Technique, 2017–2031

            10.2.1. Surface Plasmon Resonance

            10.2.2. Microcantilever

            10.2.3. Scanning Kelvin Nanoprobe

            10.2.4. Enthalpy Array

            10.2.5. Atomic Force Microscopy

            10.2.6. Electrochemical Impedance Spectroscopy

            10.2.7. Interference-based Technique

            10.2.8. Ellipsometry Technique

            10.2.9. Others

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Drug Discovery

            10.3.2. Biomolecular Interactions

            10.3.3. Detection of Disease Biomarkers

            10.3.4. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Contract Research Organizations

            10.4.2. Academic & Research Institutes

            10.4.3. Pharmaceutical & Biotechnology Industries

            10.4.4. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Technique

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Label-free Array Systems Market Analysis and Forecast

        11.1. Introduction

        11.2. Market Value Forecast, by Technique, 2017–2031

            11.2.1. Surface Plasmon Resonance

            11.2.2. Microcantilever

            11.2.3. Scanning Kelvin Nanoprobe

            11.2.4. Enthalpy Array

            11.2.5. Atomic Force Microscopy

            11.2.6. Electrochemical Impedance Spectroscopy

            11.2.7. Interference-based Technique

            11.2.8. Ellipsometry Technique

            11.2.9. Others

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Drug Discovery

            11.3.2. Biomolecular Interactions

            11.3.3. Detection of Disease Biomarkers

            11.3.4. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Contract Research Organizations

            11.4.2. Academic & Research Institutes

            11.4.3. Pharmaceutical & Biotechnology Industries

            11.4.4. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Technique

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Label-free Array Systems Market Analysis and Forecast

        12.1. Introduction

        12.2. Market Value Forecast, by Technique, 2017–2031

            12.2.1. Surface Plasmon Resonance

            12.2.2. Microcantilever

            12.2.3. Scanning Kelvin Nanoprobe

            12.2.4. Enthalpy Array

            12.2.5. Atomic Force Microscopy

            12.2.6. Electrochemical Impedance Spectroscopy

            12.2.7. Interference-based Technique

            12.2.8. Ellipsometry Technique

            12.2.9. Others

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Drug Discovery

            12.3.2. Biomolecular Interactions

            12.3.3. Detection of Disease Biomarkers

            12.3.4. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Contract Research Organizations

            12.4.2. Academic & Research Institutes

            12.4.3. Pharmaceutical & Biotechnology Industries

            12.4.4. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Technique

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Label-free Array Systems Market Analysis and Forecast

        13.1. Introduction

        13.2. Market Value Forecast, by Technique, 2017–2031

            13.2.1. Surface Plasmon Resonance

            13.2.2. Microcantilever

            13.2.3. Scanning Kelvin Nanoprobe

            13.2.4. Enthalpy Array

            13.2.5. Atomic Force Microscopy

            13.2.6. Electrochemical Impedance Spectroscopy

            13.2.7. Interference-based Technique

            13.2.8. Ellipsometry Technique

            13.2.9. Others

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Drug Discovery

            13.3.2. Biomolecular Interactions

            13.3.3. Detection of Disease Biomarkers

            13.3.4. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Contract Research Organizations

            13.4.2. Academic & Research Institutes

            13.4.3. Pharmaceutical & Biotechnology Industries

            13.4.4. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Technique

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Label-free Array Systems Market Analysis and Forecast

        14.1. Introduction

        14.2. Market Value Forecast, by Technique, 2017–2031

            14.2.1. Surface Plasmon Resonance

            14.2.2. Microcantilever

            14.2.3. Scanning Kelvin Nanoprobe

            14.2.4. Enthalpy Array

            14.2.5. Atomic Force Microscopy

            14.2.6. Electrochemical Impedance Spectroscopy

            14.2.7. Interference-based Technique

            14.2.8. Ellipsometry Technique

            14.2.9. Others

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Drug Discovery

            14.3.2. Biomolecular Interactions

            14.3.3. Detection of Disease Biomarkers

            14.3.4. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Contract Research Organizations

            14.4.2. Academic & Research Institutes

            14.4.3. Pharmaceutical & Biotechnology Industries

            14.4.4. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Israel

            14.5.4. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Technique

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (By Tier and Size of companies)

        15.2. Market Share Analysis By Company (2018)

        15.3. Company Profiles

            15.3.1. GE Healthcare

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Company Financials

                15.3.1.3. Growth Strategies

                15.3.1.4. SWOT Analysis

            15.3.2. Attana AB

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Company Financials

                15.3.2.3. Growth Strategies

                15.3.2.4. SWOT Analysis

            15.3.3. Agilent Technologies, Inc.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Company Financials

                15.3.3.3. Growth Strategies

                15.3.3.4. SWOT Analysis

            15.3.4. Danaher Corporation

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Company Financials

                15.3.4.3. Growth Strategies

                15.3.4.4. SWOT Analysis

            15.3.5. F. Hoffmann-La Roche AG

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Company Financials

                15.3.5.3. Growth Strategies

                15.3.5.4. SWOT Analysis

            15.3.6. Bio-Rad Laboratories

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Company Financials

                15.3.6.3. Growth Strategies

                15.3.6.4. SWOT Analysis

            15.3.7. GWC Technologies

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Company Financials

                15.3.7.3. Growth Strategies

                15.3.7.4. SWOT Analysis

            15.3.8. PerkinElmer, Inc.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Company Financials

                15.3.8.3. Growth Strategies

                15.3.8.4. SWOT Analysis

            15.3.9. BiOptix, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Company Financials

                15.3.9.3. Growth Strategies

                15.3.9.4. SWOT Analysis

    List of Tables

    Table 01: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 02: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Label-free Array Systems Market value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 06: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 07: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017-2027

    Table 08: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 10: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 14: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 18: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 19: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 20: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031

    Table 22: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 23: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 24: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure: 01 Global Label-free Array Systems Market Snapshot

    Figure 02: Global Label-free Array Systems Market Revenue (US$ Mn), by Application, 2021

    Figure 03: Global Label-free Array Systems Market Revenue (US$ Mn), by End-user, 2021

    Figure 04: Global Label-free Array Systems Market Value Share (%), by End-user, 2021

    Figure 05: Global Label-free Array Systems Market Value Share (%), by Technique, 2021

    Figure 06: Global Label-free Array Systems Market Value Share (%), by Application, 2021

    Figure 07: Global Label-free Array Systems Market Value Share (%), by Region, 2021

    Figure 08: U.S. Regulatory Approval Process

    Figure 09: Europe Regulatory Approval Process

    Figure 10: Latin America Regulatory Approval Process

    Figure 11: Global Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 12: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Surface Plasmon Resonance, 2017–2031

    Figure 13: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Microcantilever, 2017–2031

    Figure 14: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Scanning Kelvin Nanoprobe, 2017–2031

    Figure 15: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Enthalpy Array, 2017–2031

    Figure 16: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Interference-based Technique, 2017–2031

    Figure 17: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ellipsometry Technique, 2017–2031

    Figure 18: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Atomic Force Microscopy, 2017–2031

    Figure 19: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Electrochemical Impedance Spectroscopy, 2017–2031

    Figure 20: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031

    Figure 21: Global Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 22: Global Label-free Array Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 23: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug Discovery, 2017–2031

    Figure 24: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomolecular Interactions, 2017–2031

    Figure 25: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Detection of Disease Biomarkers, 2017–2031

    Figure 26: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031

    Figure 27: Global Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 28: Global Label-free Array Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 29: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contract Research Organizations, 2017–2031

    Figure 30: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic & Research Institutes, 2017–2031

    Figure 31: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical & Biotechnology Industries, 2017–2031

    Figure 32: Global Label-free Array Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031

    Figure 33: Global Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

    Figure 34: Global Label-free Array Systems Market Value Share Analysis, by Region, 2021 and 2031

    Figure 35: Global Label-free Array Systems Market Attractiveness Analysis, by Region, 2019-2027

    Figure 36: North America Label-free Array Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 37: North America Label-free Array Systems Market Attractiveness Analysis, by Country, 2021–2031

    Figure 38: North America Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 39: North America Label-free Array Systems Market Value Share, by Application, 2021 and 2031

    Figure 40: North America Label-free Array Systems Market Value Share, by End-user, 2021 and 2031

    Figure 41: North America Label-free Array Systems Market Value Share Analysis, by Country, 2021 and 2031

    Figure 42: North America Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 43: North America Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 44: North America Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

    Figure 45: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 46: Europe Label-free Array Systems Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 47: Europe Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 48: Europe Label-free Array Systems Market Value Share, by Application, 2021 and 2031

    Figure 49: Europe Label-free Array Systems Market Value Share, by End-user, 2021 and 2031

    Figure 50: Europe Label-free Array Systems Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 51: Europe Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 52: Europe Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 53: Europe Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

    Figure 54: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 55: Asia Pacific Label-free Array Systems Market Attractiveness Analysis, by Country/Sub-region, 2022‒2031

    Figure 56: Asia Pacific Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 57: Asia Pacific Label-free Array Systems Market Value Share, by Application, 2021 and 2031

    Figure 58: Asia Pacific Label-free Array Systems Market Value Share, by End-user, 2021 and 2031

    Figure 59: Asia Pacific Label-free Array Systems Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 60: Asia Pacific Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 61: Asia Pacific Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 62: Asia Pacific Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

    Figure 63: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 64: Latin America Label-free Array Systems Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 65: Latin America Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 66: Latin America Label-free Array Systems Market Value Share, by Application, 2021 and 2031

    Figure 67: Latin America Label-free Array Systems Market Value Share, by End-user, 2021 and 2031

    Figure 68: Latin America Label-free Array Systems Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 69: Latin America Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 70: Latin America Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 71: Latin America Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

    Figure 72: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 73: Middle East & Africa Label-free Array Systems Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 74: Middle East & Africa Label-free Array Systems Market Value Share Analysis, by Technique, 2021 and 2031

    Figure 75: Middle East & Africa Label-free Array Systems Market Value Share, by Application, 2021 and 2031

    Figure 76: Middle East & Africa Label-free Array Systems Market Value Share, by End-user, 2021 and 2031

    Figure 77: Middle East & Africa Label-free Array Systems Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 78: Middle East & Africa Label-free Array Systems Market Attractiveness Analysis, by Technique, 2022‒2031

    Figure 79: Middle East & Africa Label-free Array Systems Market Attractiveness Analysis, by Application, 2022‒2031

    Figure 80: Middle East & Africa Label-free Array Systems Market Attractiveness Analysis, by End-user, 2022‒2031

Copyright © Transparency Market Research, Inc. All Rights reserved